Inventor · disambiguated record
James M. Mckearin
Also filed as: MCKEARIN JAMES M
10 granted patents·2 pending applications·100 citations·filing 2000–2023
89Inventor score
Top patents by PatentIndex Score
12 records- 0196US10618927B1Compositions and methods for modulation of nicotinamide adenine dinucleotideMETRO INT BIOTECH LLC·Filed 2019·Granted Apr 14, 2020·29 cites·19 claims
- 0295US11878027B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2022·Granted Jan 23, 2024·2 cites·13 claims
- 0395US10548913B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2018·Granted Feb 4, 2020·18 cites·29 claims
- 0494US9919003B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2017·Granted Mar 20, 2018·16 cites·37 claims
- 0594US9855289B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2016·Granted Jan 2, 2018·19 cites·35 claims
- 0690US11939348B2Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotideMETRO INT BIOTECH LLC·Filed 2020·Granted Mar 26, 2024·2 cites·19 claims
- 0790US11464796B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2019·Granted Oct 11, 2022·6 cites·12 claims
- 0887US12485135B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2023·Granted Dec 2, 2025·0 cites·12 claims
- 0978US6646157B2Method for making HBEDGELTEX PHARMA INC·Filed 2000·Granted Nov 11, 2003·8 cites·4 claims
- 1067US11878994B1Compositions for treatment of inflammationMETRO INT BIOTECH LLC·Filed 2023·Granted Jan 23, 2024·0 cites·30 claims
- 1160US2025066413A1Compositions for treatment of inflammationMETRO INT BIOTECH LLC·Filed 2022·Application pending·0 cites
- 1249US2022324899A1Compounds and compositions for differential modulation of nicotinamide adenine dinucleotideMETRO INT BIOTECH LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James M. Mckearin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →